Jones Trading Initiates Coverage On Armata Pharmaceuticals with Buy Rating, Announces Price Target of $15
Benzinga Newsdesk 10 months ago
NewsPrice TargetInitiationAnalyst Ratings
Jones Trading analyst Debanjana Chatterjee initiates coverage on Armata Pharmaceuticals (AMEX:ARMP) with a Buy rating and announces Price Target of $15.
Jones Trading analyst Debanjana Chatterjee initiates coverage on Armata Pharmaceuticals (AMEX:ARMP) with a Buy rating and announces Price Target of $15.